Bixiye
QP31-23 Commercial Pharmacy Benefit Exclusion for Fluticasone-Salmeterol
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1721 - 1730 ee natiijooyinka 3167
Bixiye
QP32-23 Review and Update NPI Information
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
QP33-23 Provider Survey: Training & Development Focusing on Equity in Health Care
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 12, 2023
Bixiye
P17-23 Inflation Reduction Act (IRA): Part B Rebatable Drugs and Part B Insulin Cap
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023
Bixiye
P18-23 Updated Minnesota Health Care Programs (MHCP) and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023
Bixiye
P19-23 Updated Reimbursement Policy: Preventive Medicine Services, Effective June 5, 2023
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023
Bixiye
P21-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023
Bixiye
P22-23 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective June 5, 2023
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023
Bixiye
P23-23 Updated Reimbursement Policy: Lab Rebundling, Effective June 5, 2023
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023
Bixiye
P24-23 Electronic Visit Verification Requirements for Personal Care Service Providers
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 03, 2023